from Reuters: Health News https://ift.tt/2KFsKuQ
Wednesday, 28 November 2018
Biocartis partners with AstraZeneca on lung cancer diagnostics
Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.
from Reuters: Health News https://ift.tt/2KFsKuQ
from Reuters: Health News https://ift.tt/2KFsKuQ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment